title: Enzyme replacement therapy for mucopolysaccharidoses: opinions of patients and families.
abstract: OBJECTIVE
  To assess the opinions of individuals with mucopolysaccharidoses (MPS) and their parents regarding the use of enzyme replacement therapy (ERT).
  
  
  METHODS
  A validated questionnaire, including hypothetical clinical scenarios about ERT for MPS, was distributed to members of MPS support groups in the United States and Australia.
  
  
  RESULTS
  The questionnaire was completed by 249 MPS support group members. Overall, 92% were in favor of ERT where MPS causes severe physical problems but does not affect intellect, and 69% were in favor of ERT where the physical limitations are mild and intellect is spared. Only 47% were in favor of ERT where severe physical and intellectual problems are well established; however, 77% were in favor of ERT in this situation if treatment begun early prolongs life and improves quality of life.
  
  
  CONCLUSIONS
  Most respondents were in favor of ERT for MPS, even where it would not alter the intellectual deterioration. The medical community has a responsibility to advocate for their patients in situations where ERT is appropriate and recognize the economic burden and "family function burden" ERT can incur.
authors.affiliation: Bruce Lefroy Centre for Genetic Health Research, Murdoch Childrens Research Institute, Victoria, Australia.
authors.forename: David J
authors.initials: DJ
authors.lastname: Coman
authors.forename: Ian M
authors.initials: IM
authors.lastname: Hayes
authors.forename: Veronica
authors.initials: V
authors.lastname: Collins
authors.forename: Margaret
authors.initials: M
authors.lastname: Sahhar
authors.forename: J Ed
authors.initials: JE
authors.lastname: Wraith
authors.forename: Martin B
authors.initials: MB
authors.lastname: Delatycki
mesh_terms: D000328:Adult; D001315:Australia; D002648:Child; D005190:Family / Q000523:psychology*; D005260:Female; D019538:Health Care Surveys; D006801:Humans; D008297:Male; D009083:Mucopolysaccharidoses / Q000188:drug therapy* / Q000523:psychology; D010342:Patient Acceptance of Health Care; D013429:Sulfatases / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D014481:United States
chemical_list: D013429:Sulfatases